Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03261011
Recruitment Status : Unknown
Verified March 2018 by Akeso ( Akesobio Australia Pty Ltd ).
Recruitment status was:  Recruiting
First Posted : August 24, 2017
Last Update Posted : March 9, 2018
Information provided by (Responsible Party):
Akeso ( Akesobio Australia Pty Ltd )

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : September 2020